The VAPrapid2 trial aimed to determine whether measurement of bronchoalveolar lavage fluid IL-1β and IL-8 could improve antibiotic stewardship without compromising patient safety in suspected ventilator-associated pneumonia. Here, IL1B is linked to ventilator-associated pneumonia.